Impaired microvascular reactivity in patients treated with 5-fluorouracil chemotherapy regimens: Potential role of endothelial dysfunction
Background: 5-fluorouracil (5-FU) is the second most common cancer chemotherapy associated with short- and long-term cardiotoxicity. Although the mechanisms mediating these toxicities are not well understood, patients often present with symptoms suggestive of microvascular dysfunction. We tested the...
Main Authors: | Stephen T. Hammond, Dryden R. Baumfalk, Shannon K. Parr, Alec L.E. Butenas, Britton C. Scheuermann, Vanessa-Rose G. Turpin, Bradley J. Behnke, Mehmood H. Hashmi, Carl J. Ade |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | International Journal of Cardiology: Heart & Vasculature |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906723001318 |
Similar Items
-
The rate of cardiac complications in patients receiving a 24-hour dose of 5-Fluorouracil
by: Mostafa Davoodnataj, et al.
Published: (2023-12-01) -
The Impact of Metformin on the Development of Hypothyroidism and Cardiotoxicity Induced by Cyclophosphamide, Methotrexate, and Fluorouracil in Rats
by: Ahmad H. Alhowail, et al.
Published: (2023-09-01) -
Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor
by: Yuting Wu, et al.
Published: (2025-02-01) -
Efficacy of Thymoquinone and Hesperidin in Attenuating Cardiotoxicity from 5-Fluorouracil: Insights from In Vivo and In Silico Studies
by: Juveriya Farooq, et al.
Published: (2024-09-01) -
The association between systemic immune-inflammation index and cardiotoxicity related to 5-Fluorouracil in colorectal cancer
by: Xiaoqin Liu, et al.
Published: (2024-06-01)